Logo image of BASI

Bioanalytical Syst (BASI) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BASI -

16.44
+1.42 (+9.45%)
Last: 3/19/2021, 8:23:38 PM
15.65
-0.79 (-4.81%)
After Hours: 3/19/2021, 8:23:38 PM

BASI Key Statistics, Chart & Performance

Key Statistics
Market Cap182.99M
Revenue(TTM)65.44M
Net Income(TTM)-3.63M
Shares11.13M
Float8.55M
52 Week High21.08
52 Week Low3.05
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.32
PEN/A
Fwd PE182.67
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


BASI short term performance overview.The bars show the price performance of BASI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

BASI long term performance overview.The bars show the price performance of BASI in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300 400

The current stock price of BASI is 16.44 null. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.

Bioanalytical Syst / BASI Daily stock chart

BASI Latest News, Press Relases and Analysis

About BASI

Company Profile

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.

Company Info

Bioanalytical Syst

2701 KENT AVENUE

WEST LAFAYETTE IN 47906

CEO: Robert W. Leasure Jr.

Phone: 765-463-4527

Bioanalytical Syst / BASI FAQ

Can you describe the business of Bioanalytical Syst?

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.


Can you provide the latest stock price for Bioanalytical Syst?

The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.


Does BASI stock pay dividends?

BASI does not pay a dividend.


What is the ChartMill rating of Bioanalytical Syst stock?

BASI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Is Bioanalytical Syst (BASI) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BASI.


Can you provide the market cap for Bioanalytical Syst?

Bioanalytical Syst (BASI) has a market capitalization of 182.99M null. This makes BASI a Micro Cap stock.


BASI Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BASI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BASI. BASI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BASI Financial Highlights

Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.


Industry RankSector Rank
PM (TTM) -5.54%
ROA -5.77%
ROE N/A
Debt/Equity 2.31
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%38.45%
EPS 1Y (TTM)-190.91%
Revenue 1Y (TTM)36.58%

BASI Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next Y40%
Revenue Next YearN/A

BASI Ownership

Ownership
Inst Owners15.86%
Ins Owners14.77%
Short Float %N/A
Short RatioN/A